Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Routbort

Showing results (71-80 of 175) with videos related to

Pageof 18
Sort By:
Oncotarget|March 2, 2018
Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencingAndrés E Quesada, Zhihong Hu, Mark J Routbort, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 17, 2018
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndromeHabibe Kurt, Lan Zheng, Hagop M Kantarjian, et al.
American Journal of Hematology|August 14, 2013
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrowKhaled Alayed, Keyur P Patel, Sergej Konoplev, et al.
Archives of Pathology & Laboratory Medicine|October 14, 2017
A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing PracticesRakesh Nagarajan, Angela N Bartley, Julia A Bridge, et al.
Archives of Pathology & Laboratory Medicine|January 28, 2020
Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant FrequenciesAlissa Keegan, Julia A Bridge, Neal I Lindeman, et al.
Cancer Genetics|December 19, 2024
Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistryRichard K Yang, Hector Alvarez, Antony San Lucas, et al.
Oncotarget|March 15, 2018
Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumorsMeenakshi Mehrotra, Rajesh R Singh, Sanam Loghavi, et al.
Journal of Hematology & Oncology|May 9, 2015
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsKelsey Pan, Jennifer Owens, Yasir Elamin, et al.
Pageof 18

Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Oncotarget|March 2, 2018
Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencingAndrés E Quesada, Zhihong Hu, Mark J Routbort, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 17, 2018
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndromeHabibe Kurt, Lan Zheng, Hagop M Kantarjian, et al.
American Journal of Hematology|August 14, 2013
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrowKhaled Alayed, Keyur P Patel, Sergej Konoplev, et al.
Archives of Pathology & Laboratory Medicine|October 14, 2017
A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing PracticesRakesh Nagarajan, Angela N Bartley, Julia A Bridge, et al.
Archives of Pathology & Laboratory Medicine|January 28, 2020
Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant FrequenciesAlissa Keegan, Julia A Bridge, Neal I Lindeman, et al.
Cancer Genetics|December 19, 2024
Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistryRichard K Yang, Hector Alvarez, Antony San Lucas, et al.
Oncotarget|March 15, 2018
Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumorsMeenakshi Mehrotra, Rajesh R Singh, Sanam Loghavi, et al.
Journal of Hematology & Oncology|May 9, 2015
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsKelsey Pan, Jennifer Owens, Yasir Elamin, et al.
Pageof 18